Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C, Bondu S, Le Goff S, Kosmider O, Fontenay M.
Curr Opin Hematol. 2017 May;24(3):191-197. doi: 10.1097/MOH.0000000000000325.
[Dyserythropoiesis in myelodysplastic syndrome].
Iwama A.
Rinsho Ketsueki. 2018;59(10):2036-2041. doi: 10.11406/rinketsu.59.2036.
Malaria and dyserythropoiesis: a mini review.
Liu FF, Li K.
Front Cell Infect Microbiol. 2025 Sep 5;15:1679337. doi: 10.3389/fcimb.2025.1679337. eCollection 2025.
Dyserythropoiesis and congenital dyserythropoietic anaemias.
Wickramasinghe SN.
Br J Haematol. 1997 Sep;98(4):785-97. doi: 10.1046/j.1365-2141.1997.2513065.x.
Dyserythropoiesis and dyserythropoietic anaemia.
Lewis SM, Verwilghen RL.
Br J Haematol. 1972 Jul;23(1):1-4. doi: 10.1111/j.1365-2141.1972.tb03452.x.
Novel players in beta-thalassemia dyserythropoiesis and new therapeutic strategies.
Arlet JB, Dussiot M, Moura IC, Hermine O, Courtois G.
Curr Opin Hematol. 2016 May;23(3):181-8. doi: 10.1097/MOH.0000000000000231.
Spurious dyserythropoiesis.
Wang LJ, Glasser L.
Am J Clin Pathol. 2002 Jan;117(1):57-9. doi: 10.1309/T6NX-Q7HV-UH49-ADPN.
Editorial: New insights into dyserythropoiesis: from pathophysiology, molecular mechanisms to treatments for erythroid disorders.
Zhang S, Mei Y, Zhao B.
Front Cell Dev Biol. 2023 Nov 2;11:1321170. doi: 10.3389/fcell.2023.1321170. eCollection 2023.
PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.
Aoyama K, Shinoda D, Suzuki E, Nakajima-Takagi Y, Oshima M, Koide S, Rizq O, Si S, Tara S, Sashida G, Iwama A.
Leukemia. 2021 Apr;35(4):1156-1165. doi: 10.1038/s41375-020-01023-1. Epub 2020 Aug 21.
Red cell anarchy. Evidence of neoplastic dyserythropoiesis.
Lichtman MA.
Blood Cells Mol Dis. 2021 Dec;92:102618. doi: 10.1016/j.bcmd.2021.102618. Epub 2021 Oct 15.
